MS Ireland takes action

25th April 2017

MS Ireland launches two major new publications on early treatment and diagnosis of MS

Creative healing: how creative pursuits can help ease symptoms of MS

21st April 2017

Stories from MS Australia show the power of the Creative Arts to improve health and wellbeing

India celebrates MS activist for International Women’s Day

20th April 2017

Sheela Chitnis, founding member of MS Society of India (MSSI), featured in India’s #Beboldforchange campaign for International Women’s Day

World MS Day Campaign Launch

18th April 2017

World MS Day campaign on #LifewithMS begins Tuesday 18th April

Tawasol – March 2017 issue

7th April 2017

Latest news from 16 organisations in the Arab region

First treatment licensed for primary progressive MS in the US

29th March 2017

Ocrelizumab has been approved as a treatment for both relapsing and primary progressive MS in the US

Neurofilament is related to disability and brain shrinkage in MS

12th March 2017

Study suggests neurofilament levels may be used as a marker of damage to brain cells in MS

No link between oral contraceptive drugs and MS relapses

10th March 2017

Use of oral hormonal contraceptive drugs does not appear to be associated with greater risk of relapses

CCSVI: Latest findings show no association to multiple sclerosis

10th March 2017

The latest and most thorough studies do not show an association between CCSVI and MS

Long-term safety and effectiveness of fampridine

9th March 2017

Researchers find fampridine safe and effective in the long term for improving walking speed

Lifestyle risk factors in the progression of multiple sclerosis

8th March 2017

Low vitamin D levels and smoking consistently associated with MS progression

Applications for MSIF fellowships and grants now open

1st March 2017

The deadline for applications for McDonald fellowships and Du Pré Grants is 30 June 2017